General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Stockholders' Deficit

v3.21.4
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Common Stock [Member]
Total
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Balance, shares at Dec. 31, 2018 2,877   7    
Balance at Dec. 31, 2018 $ 287   $ (1,680) $ 175,820 $ (158,981)
Common stock issued, shares 9        
Common stock issued $ 1        
Restricted stock issued, shares        
Restricted stock issued        
Common stock issued through market sales, shares        
Common stock issued through market sales      
Treasury stock purchased     $ (32)    
Treasury stock purchased, shares     3    
Common stock issued through offering, net of expenses $ 94     5,868  
Common stock issued through offerings, shares 933        
Adoption of ASC 842         55
Extinguishment of Series A Shares        
Beneficial Conversion Feature in connection with Series B Issuance        
Amortization of Beneficial Conversion Feature        
Stock-based compensation expense       266  
Net loss         (3,326)
Balance, ending balance shares at Mar. 31, 2019 3,819   10    
Balance at Mar. 31, 2019 $ 382   $ (1,712) 181,954 (162,252)
Treasury stock purchased     $ 32    
Balance, shares at Dec. 31, 2018 2,877   7    
Balance at Dec. 31, 2018 $ 287   $ (1,680) 175,820 (158,981)
Net loss   $ (26,740)      
Balance, ending balance shares at Dec. 31, 2019 3,932   12    
Balance at Dec. 31, 2019 $ 393 (4,479) $ (1,721) 182,514 (185,665)
Balance, shares at Mar. 31, 2019 3,819   10    
Balance at Mar. 31, 2019 $ 382   $ (1,712) 181,954 (162,252)
Common stock issued, shares 10        
Common stock issued $ 1     72  
Treasury stock purchased        
Treasury stock purchased, shares        
Stock-based compensation expense       205  
Net loss         (5,304)
Balance, ending balance shares at Jun. 30, 2019 3,829   10    
Balance at Jun. 30, 2019 $ 383   $ (1,712) 182,231 (167,556)
Treasury stock purchased        
Common stock issued, shares        
Common stock issued        
Treasury stock purchased        
Treasury stock purchased, shares        
Dividends accrued       (75)  
Stock-based compensation expense       205  
Net loss         (7,446)
Balance, ending balance shares at Sep. 30, 2019 3,829   10    
Balance at Sep. 30, 2019 $ 383   $ (1,712) 182,361 (175,002)
Treasury stock purchased        
Common stock issued, shares 5        
Common stock issued        
Common stock issued through market sales, shares 98        
Common stock issued through market sales $ 10     218  
Treasury stock purchased     $ (9)    
Treasury stock purchased, shares     2    
Dividends accrued       (354)  
Stock-based compensation expense       289  
Net loss         (10,663)
Balance, ending balance shares at Dec. 31, 2019 3,932   12    
Balance at Dec. 31, 2019 $ 393 (4,479) $ (1,721) 182,514 (185,665)
Treasury stock purchased     9    
Common stock issued, shares 37        
Common stock issued $ 1      
Restricted stock issued, shares 6        
Restricted stock issued        
Common stock issued through market sales, shares 80        
Common stock issued through market sales $ 8     476  
Common stock issued through ESPP, shares        
Common stock issued through ESPP        
Treasury stock purchased        
Treasury stock purchased, shares        
Common stock issued through offering, net of expenses      
Common stock issued through offerings, shares        
Adoption of ASC 842        
Extinguishment of Series A Shares       (828)  
Beneficial Conversion Feature in connection with Series B Issuance       2,205  
Amortization of Beneficial Conversion Feature       (2,205)  
Stock-based compensation expense     418  
Net loss         (6,494)
Balance, ending balance shares at Mar. 31, 2020 4,055   12    
Balance at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (192,159)
Treasury stock purchased        
Balance, shares at Dec. 31, 2019 3,932   12    
Balance at Dec. 31, 2019 $ 393 (4,479) $ (1,721) 182,514 (185,665)
Net loss   (18,308)      
Balance, ending balance shares at Sep. 30, 2020 4,060   19    
Balance at Sep. 30, 2020 $ 402 (21,798) $ (1,770) 183,543 (203,973)
Balance, shares at Dec. 31, 2019 3,932   12    
Balance at Dec. 31, 2019 $ 393 (4,479) $ (1,721) 182,514 (185,665)
Net loss   (26,451)      
Balance, ending balance shares at Dec. 31, 2020 4,075   20    
Balance at Dec. 31, 2020 $ 402 (29,083) $ (1,773) 184,404 (212,116)
Balance, shares at Mar. 31, 2020 4,055   12    
Balance at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (192,159)
Common stock issued, shares        
Common stock issued      
Treasury stock purchased     $ (49)    
Treasury stock purchased, shares     7    
Stock-based compensation expense     400  
Net loss         (5,580)
Balance, ending balance shares at Jun. 30, 2020 4,055   19    
Balance at Jun. 30, 2020 $ 402 $ (1,770) 182,980 (197,739)
Treasury stock purchased     49    
Common stock issued, shares 5        
Common stock issued      
Common stock issued through ESPP, shares        
Common stock issued through ESPP        
Treasury stock purchased        
Treasury stock purchased, shares        
Dividends accrued        
Stock-based compensation expense     563  
Net loss   (6,234)     (6,234)
Balance, ending balance shares at Sep. 30, 2020 4,060   19    
Balance at Sep. 30, 2020 $ 402 (21,798) $ (1,770) 183,543 (203,973)
Treasury stock purchased        
Common stock issued, shares 15        
Common stock issued        
Common stock issued through market sales, shares        
Common stock issued through market sales      
Treasury stock purchased     $ (3)    
Treasury stock purchased, shares     1    
Dividends accrued        
Stock-based compensation expense       861  
Net loss         (8,143)
Balance, ending balance shares at Dec. 31, 2020 4,075   20    
Balance at Dec. 31, 2020 $ 402 (29,083) $ (1,773) 184,404 (212,116)
Treasury stock purchased     3    
Common stock issued, shares 9        
Common stock issued     108  
Restricted stock issued, shares 12        
Restricted stock issued        
Common stock issued through market sales, shares        
Common stock issued through market sales      
Common stock issued through ESPP, shares 36        
Common stock issued through ESPP        
Treasury stock purchased        
Treasury stock purchased, shares        
Extinguishment of Series A Shares        
Beneficial Conversion Feature in connection with Series B Issuance        
Amortization of Beneficial Conversion Feature        
Stock-based compensation expense     286  
Net loss         (4,207)
Balance, ending balance shares at Mar. 31, 2021 4,132,000   20    
Balance at Mar. 31, 2021 $ 402 $ (1,773) 184,798 (216,323)
Treasury stock purchased        
Balance, shares at Dec. 31, 2020 4,075   20    
Balance at Dec. 31, 2020 $ 402 (29,083) $ (1,773) 184,404 (212,116)
Net loss   (11,214)      
Balance, ending balance shares at Sep. 30, 2021 4,194   20    
Balance at Sep. 30, 2021 $ 403 (38,648) $ (1,773) 186,052 (223,330)
Balance, shares at Mar. 31, 2021 4,132,000   20    
Balance at Mar. 31, 2021 $ 402 $ (1,773) 184,798 (216,323)
Common stock issued, shares 10        
Common stock issued        
Treasury stock purchased        
Treasury stock purchased, shares        
Stock-based compensation expense     551  
Net loss         (3,446)
Balance, ending balance shares at Jun. 30, 2021 4,142   20    
Balance at Jun. 30, 2021 $ 402 $ (1,773) 185,349 (219,769)
Treasury stock purchased        
Common stock issued, shares 13        
Common stock issued     226  
Common stock issued through ESPP, shares 39        
Common stock issued through ESPP $ 1        
Treasury stock purchased        
Treasury stock purchased, shares        
Stock-based compensation expense     477  
Net loss   (3,561)     (3,561)
Balance, ending balance shares at Sep. 30, 2021 4,194   20    
Balance at Sep. 30, 2021 $ 403 $ (38,648) $ (1,773) $ 186,052 $ (223,330)
Treasury stock purchased